Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis.
Müller J, Roos I, Kalincik T, Lorscheider J, Galli E, Benkert P, Schädelin S, Sharmin S, Einsiedler M, Hänni P, Schmid J, Kuhle J, Derfuss T, Granziera C, Ziemssen T, Siepmann T, Yaldizli Ö. Müller J, et al. Among authors: galli e. Brain Behav. 2024 May;14(5):e3498. doi: 10.1002/brb3.3498. Brain Behav. 2024. PMID: 38688877 Free PMC article.
GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis.
Galli E, Hartmann FJ, Schreiner B, Ingelfinger F, Arvaniti E, Diebold M, Mrdjen D, van der Meer F, Krieg C, Nimer FA, Sanderson N, Stadelmann C, Khademi M, Piehl F, Claassen M, Derfuss T, Olsson T, Becher B. Galli E, et al. Nat Med. 2019 Aug;25(8):1290-1300. doi: 10.1038/s41591-019-0521-4. Epub 2019 Jul 22. Nat Med. 2019. PMID: 31332391 Free PMC article.
Mass Cytometry of CSF Identifies an MS-Associated B-cell Population.
Johansson D, Rauld C, Roux J, Regairaz C, Galli E, Callegari I, Raad L, Waldt A, Cuttat R, Roma G, Diebold M, Becher B, Kuhle J, Derfuss T, Carballido JM, Sanderson NSR. Johansson D, et al. Among authors: galli e. Neurol Neuroimmunol Neuroinflamm. 2021 Feb 15;8(2):e943. doi: 10.1212/NXI.0000000000000943. Print 2021 Mar. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33589541 Free PMC article.
Update on treatment in multiple sclerosis.
Callegari I, Derfuss T, Galli E. Callegari I, et al. Among authors: galli e. Presse Med. 2021 Jun;50(2):104068. doi: 10.1016/j.lpm.2021.104068. Epub 2021 May 24. Presse Med. 2021. PMID: 34033862 Free article. Review.
Immunological Predictors of Dimethyl Fumarate-Induced Lymphopenia.
Diebold M, Galli E, Kopf A, Sanderson N, Callegari I, Ingelfinger F, Núñez NG, Benkert P, Kappos L, Kuhle J, Becher B, Claassen M, Derfuss T. Diebold M, et al. Among authors: galli e. Ann Neurol. 2022 May;91(5):676-681. doi: 10.1002/ana.26328. Epub 2022 Mar 4. Ann Neurol. 2022. PMID: 35170072 Free PMC article.
High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis.
Diebold M, Galli E, Kopf A, Sanderson NSR, Callegari I, Benkert P, Gonzalo Núñez N, Ingelfinger F, Herms S, Cichon S, Kappos L, Kuhle J, Becher B, Claassen M, Derfuss T. Diebold M, et al. Among authors: galli e. Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2205042119. doi: 10.1073/pnas.2205042119. Epub 2022 Jul 26. Proc Natl Acad Sci U S A. 2022. PMID: 35881799 Free PMC article.
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis.
Ulutekin C, Galli E, Schreiner B, Khademi M, Callegari I, Piehl F, Sanderson N, Kirschenbaum D, Mundt S, Filippi M, Furlan R, Olsson T, Derfuss T, Ingelfinger F, Becher B. Ulutekin C, et al. Among authors: galli e. Cell Rep Med. 2024 Jan 16;5(1):101351. doi: 10.1016/j.xcrm.2023.101351. Epub 2023 Dec 21. Cell Rep Med. 2024. PMID: 38134930 Free PMC article.
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.
Benkert P, Maleska Maceski A, Schaedelin S, Oechtering J, Zadic A, Vilchez Gomez JF, Melie-Garcia L, Cagol A, Galbusera R, Subramaniam S, Lorscheider J, Galli E, Mueller J, Fischer-Barnicol B, Achtnichts L, Findling O, Lalive PH, Bridel C, Uginet M, Müller S, Pot C, Mathias A, Du Pasquier R, Salmen A, Hoepner R, Chan A, Disanto G, Zecca C, D'Souza M, Hemkens LG, Yaldizli Ö, Derfuss T, Roth P, Gobbi C, Brassat D, Tackenberg B, Pedotti R, Raposo C, Oksenberg J, Wiendl H, Berger K, Hermesdorf M, Piehl F, Conen D, Buser A, Kappos L, Khalil M, Granziera C, Abdelhak A, Leppert D, Willemse EAJ, Kuhle J; Swiss MS Cohort study (SMSC). Benkert P, et al. Among authors: galli e. Ann Neurol. 2024 Oct 16. doi: 10.1002/ana.27096. Online ahead of print. Ann Neurol. 2024. PMID: 39411917
Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch.
Callegari I, Schneider M, Berloffa G, Mühlethaler T, Holdermann S, Galli E, Roloff T, Boss R, Infanti L, Khanna N, Egli A, Buser A, Zimmer G, Derfuss T, Sanderson NSR. Callegari I, et al. Among authors: galli e. EMBO Rep. 2022 Jul 5;23(7):e53956. doi: 10.15252/embr.202153956. Epub 2022 May 12. EMBO Rep. 2022. PMID: 35548920 Free PMC article.
Twin study reveals non-heritable immune perturbations in multiple sclerosis.
Ingelfinger F, Gerdes LA, Kavaka V, Krishnarajah S, Friebel E, Galli E, Zwicky P, Furrer R, Peukert C, Dutertre CA, Eglseer KM, Ginhoux F, Flierl-Hecht A, Kümpfel T, De Feo D, Schreiner B, Mundt S, Kerschensteiner M, Hohlfeld R, Beltrán E, Becher B. Ingelfinger F, et al. Among authors: galli e. Nature. 2022 Mar;603(7899):152-158. doi: 10.1038/s41586-022-04419-4. Epub 2022 Feb 16. Nature. 2022. PMID: 35173329 Free PMC article.
523 results